1.Jain R, Mathur M, Lan J, Costales A, Atallah G, Ramurthy S, Subramanian S, Setti L, Feucht P, Warne B, Doyle L, Basham S, Jefferson AB, Lindvall M, Appleton BA, Shafer CM.. (2015) Discovery of Potent and Selective RSK Inhibitors as Biological Probes., 58 (17):[PMID:26270416][10.1021/acs.jmedchem.5b00450]
2.Mrozowski, Roman M RM and 9 more authors. 2012-02-14 Improving the affinity of SL0101 for RSK using structure-based design. [PMID:23519677]
3.Liang, Chengyuan C and 6 more authors. 2018-05-10 The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review. [PMID:29631132]
4.Narayan, Satya S and 7 more authors. 2019-01-01 ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. [PMID:30384048]
5.Casalvieri, Kimberly A; Matheson, Christopher J; Backos, Donald S and Reigan, Philip. 2020-03-01 Substituted pteridinones as p90 ribosomal S6 protein kinase (RSK) inhibitors: A structure-activity study. [PMID:31982240]